Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M28.6Revenue $M1.3Net Margin (%)-1,094.7Altman Z-Score-3.9
Enterprise Value $M20.7EPS $-1.3Operating Margin %-1,074.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-32.9Pre-tax Margin (%)-1,093.5Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %-38.9Quick Ratio7.4Cash flow > EarningsY
Price/Sales20.65-y EBITDA Growth Rate %-59.9Current Ratio7.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-67.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-74.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M11.8ROIC % (ttm)-302.3Gross Margin Increase y-yY

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ROSG is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

Quarterly/Annual Reports about ROSG:

    News about ROSG:

    Articles On GuruFocus.com
    Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance Nov 18 2014 
    Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update Sep 08 2009 
    Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd. Jan 08 2009 
    Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

    More From Other Websites
    Rosetta Genomics Receives Conditional Approval from New York State for Lung Biomarker Aug 06 2015
    Rosetta Genomics Receives Accreditation from College of American Pathologists for its Laboratory in... Aug 06 2015
    Rosetta Genomics Expands High-Value Molecular Diagnostic Offering with Launch of OncoGxSelect™ Jul 28 2015
    ROSG: Strong Revenue Growth Expected for 1H15 and the Full Year 2015 Jul 09 2015
    Rosetta Genomics Files Pro Forma Financials in Connection with PersonalizeDx Acquisition Jul 08 2015
    Rosetta Genomics Announces Participation in Cantor Fitzgerald’s Inaugural “From Bench to... Jul 01 2015
    Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services Jun 16 2015
    US Military Accidentally Ships Live Anthrax via FedEx; These Are the Stocks to Watch in Its Wake Jun 01 2015
    Rosetta Genomics Launches OncoGxOne™ May 28 2015
    Rosetta Genomics Announces Selection of First Pilot Project Grant under Strategic Alliance with... May 26 2015
    Rosetta Genomics Launches Two Assays for Bladder Cancer May 14 2015
    Rosetta Genomics Receives Additional U.S. Patent Protection for the Cancer Origin Test™ May 13 2015
    Data on Rosetta Genomics’ Novel Thyroid Nodule Classification Assay to be Presented at the... May 12 2015
    Rosetta Genomics’ Patent on Therapeutic Use of miR-34a Upheld by European Patent Office in... Apr 29 2015
    Rosetta Genomics Announces Data Published in Leukemia Research Apr 20 2015
    Rosseta Genomics (ROSG) Stock Continues To Climb Today on Analyst Upgrade Apr 17 2015
    Rosetta Genomics Shares Upgraded At Cantor Apr 17 2015
    Rosetta Genomics (ROSG) Stock is Spiking on Receipt of Cancer Origin Test Patent Apr 16 2015
    Rosetta Genomics Receives Key U.S. Patent Allowance for its Cancer of Origin Diagnostic Assay Apr 16 2015
    ROSG: Acquisition of PersonalizeDx Will Accelerate Substantial Revenue Growth Apr 15 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)